This month, I would like to highlight the on-going discussions on the draft Commission delegated regulation on “Criteria for the designation of antimicrobials to be reserved for the treatment of certain infections in humans”.
As explained below, a resolution to object to this delegated regulation is to be voted on in the European Parliament. The Delegated Act is based on the “One Health” approach, therefore we encourage European institutions to support this act, as drafted by the European Commission.
UEVP was active during the drafting of this act and now encourages its members to be active on national levels in supporting the Delegated Act as a complete and science-based approach to AMR.
Download the newsletter file, in English, in the link below or visit this link to read it in other languages.
